Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

Tooth disorders accounted for an annual average of 1,944,000 emergency department visits during 2020 to 2022, according to a ...

Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic musculoskeletal disease that predominantly affects the ...

Immunotherapy has revolutionized cancer treatment by mobilizing the immune system to attack tumor cells. Major advances, such as immune checkpoint inhibitors (notably against the PD-1 protein), have ...

Be it peanuts or other triggers, many families live with the day-to-day risk that their child might experience a sudden and ...

It is known that vasculopathy plays a pivotal role in the pathogenesis of systemic sclerosis (SSc). Vasoactive vasodilating drugs (VVD) are an option. The most recent treatment recommendations from ...

New research from the University of Minnesota Medical School suggests that different genetic forms of autism may lead to ...

During the early days of the COVID-19 pandemic, there was a decline in the physical fitness of U.S. youth, according to a ...

Adolescents and young adults with chronic diseases need special care—and pediatric rheumatological conditions can persist ...

Alcohol-related liver disease deaths are increasing—and they're rising faster in some groups, including women, young adults ...

A research team at Toho University has revealed that ferulic acid (FA), a polyphenol abundant in rice bran, suppresses ...

About 525,000 more deaths occurred among US adults in 2023 than would be expected had pre-2010 mortality trends continued.